Impaired angiogenesis and extracellular matrix metabolism in autosomal-dominant hyper-IgE syndrome
Authors:
- Natalia I. DmitrievaNDNatalia I. Dmitrieva
- Avram D. WaltsAWAvram D. Walts
- Dai Phuong NguyenDNDai Phuong Nguyen
- Alex GrubbAGAlex Grubb
- Xue ZhangXZXue Zhang
- Xujing WangXWXujing Wang
- Xianfeng PingXPXianfeng Ping
- Hui JinHJHui Jin
- Zhen YuZYZhen Yu
- Zu-Xi YuZYZu-Xi Yu
- Dan YangDYDan Yang
- Robin SchwartzbeckRSRobin Schwartzbeck
- 3 August 2020
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (8) , 4167-4181
Abstract
There are more than 7000 described rare diseases, most lacking specific treatment. Autosomal-dominant hyper-IgE syndrome (AD-HIES, also known as Job’s syndrome) is caused by mutations in STAT3. These patients present with immunodeficiency accompanied by severe nonimmunological features, including skeletal, connective tissue, and vascular abnormalities, poor postinfection lung healing, and subsequent pulmonary failure. No specific therapies are available for these abnormalities. Here, we investigated underlying mechanisms in order to identify therapeutic targets. Histological analysis of skin wounds demonstrated delayed granulation tissue formation and vascularization during skin-wound healing in AD-HIES patients. Global gene expression analysis in AD-HIES patient skin fibroblasts identified deficiencies in a STAT3-controlled transcriptional network regulating extracellular matrix (ECM) remodeling and angiogenesis, with hypoxia-inducible factor 1α (HIF-1α) being a major contributor. Consistent with this, histological analysis of skin wounds and coronary arteries from AD-HIES patients showed decreased HIF-1α expression and revealed abnormal organization of the ECM and altered formation of the coronary vasa vasorum. Disease modeling using cell culture and mouse models of angiogenesis and wound healing confirmed these predicted deficiencies and demonstrated therapeutic benefit of HIF-1α–stabilizing drugs. The study provides mechanistic insights into AD-HIES pathophysiology and suggests potential treatment options for this rare disease.Keywords
Funding Information
- NHLBI (Intramural program)
- NIAID (Intramural program)
This publication has 71 references indexed in Scilit:
- Hypoxia-Inducible Factors in Physiology and MedicineCell, 2012
- Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1Cell, 2011
- Inactivation of IL11 Signaling Causes Craniosynostosis, Delayed Tooth Eruption, and Supernumerary TeethThe American Journal of Human Genetics, 2011
- The vasa vasorum in diseased and nondiseased arteriesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndromeJournal of Allergy and Clinical Immunology, 2010
- Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in miceJournal of Clinical Investigation, 2010
- Vascular Extracellular Matrix and Arterial MechanicsPhysiological Reviews, 2009
- Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndromeNature, 2008
- STAT3 inhibits the degradation of HIF-1α by pVHL-mediated ubiquitinationExperimental & Molecular Medicine, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005